2014
DOI: 10.1111/aos.12411
|View full text |Cite
|
Sign up to set email alerts
|

The risk of newly developed visual impairment in treated normal‐tension glaucoma: 10‐year follow‐up

Abstract: ABSTRACT.Purpose: To investigate the risk and risk factors for newly developed visual impairment in treated patients with normal-tension glaucoma (NTG) followed up on for 10 years. The cumulative risk of visual impairment in at least one eye was 2.8% at 10 years and 8.7% at 15 years. The risk factors for visual impairment from treated NTG were worse VF mean deviation (MD) at diagnosis and longer follow-up period. Conclusion: The risk of newly developed visual impairment in the treated patients with NTG was rel… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
8
0

Year Published

2015
2015
2019
2019

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(8 citation statements)
references
References 27 publications
(38 reference statements)
0
8
0
Order By: Relevance
“…; Choi et al. ). One large cohort study was performed in the USA and has resulted in many analyses published, and one other was performed in Sweden.…”
Section: Discussionmentioning
confidence: 98%
See 1 more Smart Citation
“…; Choi et al. ). One large cohort study was performed in the USA and has resulted in many analyses published, and one other was performed in Sweden.…”
Section: Discussionmentioning
confidence: 98%
“…Only a few numbers of studies have evaluated the progression of visual field defects in glaucoma patients treated and followed by usual care (De Moraes et al 2009, 2011, 2013aFolgar et al 2010;Prata et al 2010;Heijl et al 2013;Bertrand et al 2014;Choi et al 2014). One large cohort study was performed in the USA and has resulted in many analyses published, and one other was performed in Sweden.…”
Section: Discussionmentioning
confidence: 99%
“…About 20% of such patients experience progressive optic neuropathy five years after 30% IOP reduction from normal baseline levels 3 , even sometimes to such deeply subnormal IOP that ocular hypotension then poses a separate risk of vision loss 29 . Therefore, without denying the clear pathogenic role of highly elevated IOP, there seemingly exist one or more IOP-independent mechanisms of progressive optic neuropathy that operate at normal IOP and can be unresponsive to IOP reduction 30,31 .…”
Section: Introductionmentioning
confidence: 99%
“…Notwithstanding that IOP reduction may slow the glaucomatous process in some of these patients, 11 – 13 there clearly must exist an IOP-independent mechanism of progressive optic neuropathy unresponsive to IOP reduction to any level. 10 , 14 …”
mentioning
confidence: 99%